Car Battery Pioneer Says New Breakthrough Will Lower Cobalt Use
(Bloomberg) -- The scientist-turned-entrepreneur behind a battery technology adopted by chemical giants BASF SE and Johnson Matthey Plc is back with another invention -- one he claims will boost electric vehicle performance for years to come.
Kenan Sahin, 77, says his latest innovation reduces the need for cobalt, a key battery material, to only the most critical areas in order to lower costs. The blueish-gray element is mined mostly in Democratic Republic of Congo and prices have spiked in recent years amid fears of shortages for battery-powered cars.
To read more about the highs and lows of the battery-metals fever, click here
Sahin's new invention, called GEMX, can be used in a number of types of nickel-based power packs and has been granted patents in the U.S., the European Union, China and Japan -- the major battery manufacturing markets. In Berlin this week for an annual car industry conference, he said he's in talks with large manufacturers and one has already agreed to buy a license.
“We're hoping we will get this into the hands of the major producers,” Sahin said in a phone interview. The technique could lower cobalt content to as little as 4 percent of battery cathodes, he said, from about 20 percent needed in some now.
For details on Tesla's Model 3 battery, which uses less cobalt, click here
Lowering the amount of cobalt in batteries would help reduce reliance on war-torn Congo, where child labor and unsafe working practices are a headache for carmakers like BMW AG and Volkswagen AG, whose supply chains are under scrutiny. Sahin's technique consists of inserting the element into specific spaces within the chemical structure of cathodes so less is needed.
His story is an unlikely tale of success. After traveling to the U.S. from Turkey at age 16 on an exchange program, he went on to build a customer-service software company that he sold to Lucent Technologies for $1.5 billion. He then pumped almost $100 million of his own fortune into developing cathodes, the mission-critical chemical compounds that determine how far a car battery can run between charges.
During his quest, Sahin was up against some of the world's biggest chemical companies as they raced to corner the nascent market for battery materials. But rather than go head on, Sahin opted to work with them.
Playing Catch Up
BASF was keen to catch up with cathode market leader Umicore SA, and in April 2016 turned to Sahin's CAMX Power company and its lithium nickel-oxide formula. Two months later, Johnson Matthey followed suit. The London-based company had been in talks to acquire Sahin's company until BASF pounced on a license, forcing it to settle for a similar arrangement, according to a person familiar with the situation, who asked not to be identified. Sahin declined to discuss relationships with the two companies, whose representatives didn't respond to requests for comment.
Both companies took Sahin's CAMX technology and developed it further. Johnson Matthey now plans to spend as much as 200 million pounds ($260 million) on ramping up production of cathodes based on the invention. BASF has announced its own plan to invest as much as 400 million euros on making cathodes, although it hasn't yet specified which chemistry it plans to use.
To contact the reporter on this story: Andrew Noël in London at anoel@bloomberg.net
To contact the editors responsible for this story: Anthony Palazzo at apalazzo@bloomberg.net, Tara Patel, John Bowker
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.